Literature DB >> 15084967

Pancreatic intraepithelial neoplasia.

Kyoichi Takaori1, Ralph H Hruban, Anirban Maitra, Nobuhiko Tanigawa.   

Abstract

Great efforts have been devoted to detecting preinvasive precursors to ductal carcinoma of the pancreas in the hope of improving the currently bleak prognosis of invasive pancreatic cancer. Intensive investigations of the pancreas have led to the recognition of intraductal papillary mucinous neoplasms (IPMNs) and the detection of preinvasive precursors to conventional ductal carcinoma. The pancreatic intraepithelial neoplasia (PanIN) nomenclature for precursor lesions of ductal carcinoma was developed at the "Pancreatic Cancer Think Tank" held in the United States in 1999. However, some reports of precursor lesions have suggested that these definitions do not encompass the full spectrum of precursors of ductal carcinoma, and these issues were the subject of the "Forum on Carcinoma In Situ of the Pancreas" held in Japan in 2002. After this forum, it became clear that the existing definitions of PanINs needed to be revised and expanded. Both participants of the Pancreatic Cancer Think Tank and the Forum gathered together at a meeting on precursor lesions of pancreatic cancer in 2003, and an international consensus on the diagnostic criteria for PanINs and IPMNs was created. We describe herein the current understanding of precursor lesions of pancreatic cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15084967     DOI: 10.1097/00006676-200404000-00008

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  20 in total

Review 1.  Target discovery and validation in pancreatic cancer.

Authors:  Robert M Beaty; Mads Gronborg; Jonathan R Pollack; Anirban Maitra
Journal:  Methods Mol Biol       Date:  2007

2.  MicroRNAs in pancreatic ductal adenocarcinoma.

Authors:  Jong Y Park; James Helm; Domenico Coppola; Donghwa Kim; Mokenge Malafa; Seung Joon Kim
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

3.  Phase IIA trial testing erlotinib as an intervention against intraductal pancreatic mucinous neoplasms.

Authors:  Steven Lipkin; John Lee; David Imagawa; Stephen M Hewitt; Chris Tucker; Jason A Zell; Vanessa Wong; Angela Garcia; Rachel Gonzalez; Gary Della Zanna; Ellen Richmond; L M Rodriguez; M Bigg; F Schnoll-Sussmans; Frank Meyskens
Journal:  Cancer Prev Res (Phila)       Date:  2011-04

Review 4.  Therapeutic options for the management of pancreatic cancer.

Authors:  Maria L Rossi; Azeem A Rehman; Christopher S Gondi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

5.  Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.

Authors:  Meritxell Gironella; Mylène Seux; Min-Jue Xie; Carla Cano; Richard Tomasini; Julien Gommeaux; Stephane Garcia; Jonathan Nowak; Man Lung Yeung; Kuan-Teh Jeang; Amandine Chaix; Ladan Fazli; Yoshiharu Motoo; Qing Wang; Palma Rocchi; Antonio Russo; Martin Gleave; Jean-Charles Dagorn; Juan L Iovanna; Alice Carrier; Marie-Josèphe Pébusque; Nelson J Dusetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

Review 6.  Molecular genetics of pancreatic intraepithelial neoplasia.

Authors:  Georg Feldmann; Robert Beaty; Ralph H Hruban; Anirban Maitra
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-05-29

7.  Mucins in pancreatic cancer: biological role, implications in carcinogenesis and applications in diagnosis and therapy.

Authors:  Hyerim Suh; Krishna Pillai; David Lawson Morris
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

8.  Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer.

Authors:  Giuseppe R Diaferia; Chiara Balestrieri; Elena Prosperini; Paola Nicoli; Paola Spaggiari; Alessandro Zerbi; Gioacchino Natoli
Journal:  EMBO J       Date:  2016-01-14       Impact factor: 11.598

9.  Pancreatic intraepithelial neoplasia in heterotopic pancreas: incidentally diagnosed on endoscopic mucosal resection of a duodenal polyp.

Authors:  Sarah Safadi; David R Martin; Tarun Rustagi
Journal:  BMJ Case Rep       Date:  2018-06-23

10.  Expression of orotate phosphoribosyltransferase (OPRT) in hepatobiliary and pancreatic carcinoma.

Authors:  Yuichi Sanada; Kazuhiro Yoshida; Masahiro Ohara; Yasuhiro Tsutani
Journal:  Pathol Oncol Res       Date:  2007-07-03       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.